Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2009 1
2011 1
2012 2
2013 4
2016 2
2017 2
2018 2
2019 1
2020 5
2021 3
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Obesity-induced inflammation exacerbates clonal hematopoiesis.
Pasupuleti SK, Ramdas B, Burns SS, Palam LR, Kanumuri R, Kumar R, Pandhiri TR, Dave UP, Yellapu NK, Zhou X, Zhang C, Sandusky GE, Yu Z, Honigberg MC, Bick AG, Griffin GK, Niroula A, Ebert BL, Paczesny S, Natarajan P, Kapur R. Pasupuleti SK, et al. Among authors: burns ss. J Clin Invest. 2023 Jun 1;133(11):e163968. doi: 10.1172/JCI163968. J Clin Invest. 2023. PMID: 37071471 Free PMC article.
Targeting SHP2 phosphatase in hematological malignancies.
Kanumuri R, Kumar Pasupuleti S, Burns SS, Ramdas B, Kapur R. Kanumuri R, et al. Among authors: burns ss. Expert Opin Ther Targets. 2022 Apr;26(4):319-332. doi: 10.1080/14728222.2022.2066518. Epub 2022 May 3. Expert Opin Ther Targets. 2022. PMID: 35503226 Free PMC article. Review.
Il-1r1 drives leukemogenesis induced by Tet2 loss.
Burns SS, Kumar R, Pasupuleti SK, So K, Zhang C, Kapur R. Burns SS, et al. Leukemia. 2022 Oct;36(10):2531-2534. doi: 10.1038/s41375-022-01665-3. Epub 2022 Aug 12. Leukemia. 2022. PMID: 35962058 Free PMC article. No abstract available.
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.
Chang LS, Oblinger JL, Smith AE, Ferrer M, Angus SP, Hawley E, Petrilli AM, Beauchamp RL, Riecken LB, Erdin S, Poi M, Huang J, Bessler WK, Zhang X, Guha R, Thomas C, Burns SS, Gilbert TSK, Jiang L, Li X, Lu Q, Yuan J, He Y, Dixon SAH, Masters A, Jones DR, Yates CW, Haggarty SJ, La Rosa S, Welling DB, Stemmer-Rachamimov AO, Plotkin SR, Gusella JF, Guinney J, Morrison H, Ramesh V, Fernandez-Valle C, Johnson GL, Blakeley JO, Clapp DW; Synodos for NF2 Consortium. Chang LS, et al. Among authors: burns ss. PLoS One. 2021 Jul 15;16(7):e0252048. doi: 10.1371/journal.pone.0252048. eCollection 2021. PLoS One. 2021. PMID: 34264955 Free PMC article.
Treatment of vestibular schwannoma cells with ErbB inhibitors.
Bush ML, Burns SS, Oblinger J, Davletova S, Chang LS, Welling DB, Jacob A. Bush ML, et al. Among authors: burns ss. Otol Neurotol. 2012 Feb;33(2):244-57. doi: 10.1097/MAO.0b013e31823e287f. Otol Neurotol. 2012. PMID: 22222570 Free PMC article.
25 results